Verano Holdings: Analysts Expect $122 Million In EBITDA For Q2

Verano Holdings (CSE: VRNO) announced that they will be reporting their second quarter financials before the market opens on August 10.

Analysts have a consensus C$38.46 12-month price target on the company, via a total of 7 analysts, with 2 analysts having a strong buy rating, and 5 analysts have a buy rating. The street high comes from BTIG with a C$47 price target, and the lowest target comes in at C$19.70.

Six analysts have revenue estimates for the second quarter. The mean between all 6 is C$228.56 million; this number has been revised higher from C$205.51 million at the start of the year. The street high is C$247.37 million while the lowest sits at C$195.80 million.

Four analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 63.55%, with this number being revised slightly downwards from 65% at the start of the year. Street high goes to Beacon Securities with a 71% estimate and the lowest sits at 60%.

Onto EBITDA estimates, there are currently 6 analysts who have second quarter EBITDA estimates. The mean is currently C$122.58 million, with this number being higher than at the start of the year. Street high goes to Roth Capital with a C$248.46 million EBITDA estimate and the lowest being a C$82.10 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

IAMGOLD Q3 Earnings: Market Responds With MASSIVE Price Lift

G Mining Q3 Earnings: Costs Down, Production Up

Endeavour Silver Q3 Earnings: On The Upswing

Recommended

Silver47 Hits 606 g/t Over 9.7 Metres Silver Equivalent In Final Assays From 2025 Drill Program At Red Mountain

Altamira Gold Encounters Second Porphyry Body, Hitting 3.5 g/t Gold Over 8.0 Metres

Related News

Organigram: Consensus Price Target Falls To $3.55

On November 23rd, Organigram Holdings (TSX: OGI) announced its fourth quarter fiscal 2021 results. The...

Sunday, November 28, 2021, 01:18:00 PM

Sundial: Canaccord Drops Target To $0.50 Following Q1 Results

On Monday, Sundial Growers Inc. (Nasdaq: SNDL) reported its first quarter financial results. The company...

Wednesday, May 18, 2022, 03:44:00 PM

Antibe Therapeutics: Canaccord Initiates Coverage, Issues $1.50 Price Target

Recently, Canaccord Genuity’s Tania Gonsalves initiated coverage on Antibe Therapeutics (TSXV: ATE), a biotechnology company...

Tuesday, August 18, 2020, 01:46:28 PM

Aphria: Canaccord Upgrades Price Target To $11.00 Following SweetWater Transaction

On Wednesday, Aphria Inc (TSX: APHA) (NASDAQ: APHA) announced that it had entered an agreement...

Thursday, November 5, 2020, 03:01:00 PM

Apple: Analysts Anticipate Q4 Revenues Of $84.85 Billion

Apple (NASDAQ: AAPL) will be reporting its fourth quarter financial results on October 27th after...

Tuesday, October 26, 2021, 05:25:00 PM